| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0002 |
| mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.002 |
| mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.49 |
0.003 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.009 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |